Autolus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.About AUTL
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.
CEOChristian Martin Itin
CEOChristian Martin Itin
Employees647
Employees647
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2018
Founded2018
Employees647
Employees647
AUTL Key Statistics
Market cap435.14M
Market cap435.14M
Price-Earnings ratio-1.86
Price-Earnings ratio-1.86
Dividend yield—
Dividend yield—
Average volume2.62M
Average volume2.62M
High today$1.64
High today$1.64
Low today$1.58
Low today$1.58
Open price$1.59
Open price$1.59
Volume583.01K
Volume583.01K
52 Week high$2.80
52 Week high$2.80
52 Week low$1.11
52 Week low$1.11
Stock Snapshot
The current Autolus Therapeutics(AUTL) stock price is $1.64, with a market capitalization of 435.14M. The stock trades at a price-to-earnings (P/E) ratio of -1.86.
During the trading session on 2025-12-19, Autolus Therapeutics(AUTL) shares reached a daily high of $1.64 and a low of $1.58. At a current price of $1.64, the stock is +3.5% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 583.01K, compared to an average daily volume of 2.62M.
The stock's 52-week range extends from a low of $1.11 to a high of $2.80.
The stock's 52-week range extends from a low of $1.11 to a high of $2.80.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%